TipRanks
Advertisement
Advertisement
Roth Capital biopharmaceuticals analyst holds a webinar
PremiumThe FlyRoth Capital biopharmaceuticals analyst holds a webinar
3M ago
Analyst Reiterates Buy on MediciNova as Advancing Pipeline and Upcoming ALS Catalysts Support Unchanged $6 Price Target
Premium
Ratings
Analyst Reiterates Buy on MediciNova as Advancing Pipeline and Upcoming ALS Catalysts Support Unchanged $6 Price Target
4M ago
MediciNova Shareholders Reject Proposal to Increase Authorized Stock
Premium
Company Announcements
MediciNova Shareholders Reject Proposal to Increase Authorized Stock
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―